These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 18654047

  • 1. Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism.
    Mishina M, Komaba Y, Kobayashi S, Kominami S, Fukuchi T, Mizunari T, Teramoto A, Katayama Y.
    Neurol Med Chir (Tokyo); 2008 Jul; 48(7):292-7. PubMed ID: 18654047
    [Abstract] [Full Text] [Related]

  • 2. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 3. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 4. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
    Edaravone Acute Infarction Study Group.
    Cerebrovasc Dis; 2003 May; 15(3):222-9. PubMed ID: 12715790
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014 May; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction.
    Mishina M, Komaba Y, Kobayashi S, Tanaka N, Kominami S, Fukuchi T, Mizunari T, Hamamoto M, Teramoto A, Katayama Y.
    Neurol Med Chir (Tokyo); 2005 Jul; 45(7):344-8; discussion 348. PubMed ID: 16041179
    [Abstract] [Full Text] [Related]

  • 7. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
    Tsukamoto Y, Takizawa S, Takahashi W, Mase H, Miyachi H, Miyata T, Takagi S.
    J Stroke Cerebrovasc Dis; 2011 Jul; 20(2):111-6. PubMed ID: 20580255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyperbaric oxygen combined with intravenous edaravone for treatment of acute embolic stroke: a pilot clinical trial.
    Imai K, Mori T, Izumoto H, Takabatake N, Kunieda T, Watanabe M.
    Neurol Med Chir (Tokyo); 2006 Aug; 46(8):373-8; discussion 378. PubMed ID: 16936457
    [Abstract] [Full Text] [Related]

  • 11. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
    Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M.
    J Neurol Sci; 2004 Jun 15; 221(1-2):11-7. PubMed ID: 15178207
    [Abstract] [Full Text] [Related]

  • 12. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S.
    Stroke; 2009 Feb 15; 40(2):626-31. PubMed ID: 19095969
    [Abstract] [Full Text] [Related]

  • 13. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr 15; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 14. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K, Yamada K, Yamatoku M, Sakurai K, Takaishi S, Kato B, Hirayama T, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2012 Feb 15; 21(2):102-7. PubMed ID: 21215657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.
    Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, Iguchi Y, Shibazaki K.
    J Neurol Sci; 2012 Feb 15; 313(1-2):132-6. PubMed ID: 21967833
    [Abstract] [Full Text] [Related]

  • 19. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct 15; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 20. Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator.
    Lee XR, Xiang GL.
    Clin Neurol Neurosurg; 2018 Apr 15; 167():157-161. PubMed ID: 29501045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.